NCT03793517
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- Peking University Institute of Hematology,Beijing Beijing, Beijing Municipality, China
Clinical trial condition
Leukemia
Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.
4,419 public trials
1,034 recruiting studies
Leukemia trial results
NCT04209244
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Aalborg University Hospital Aalborg, Denmark
- Aarhus University Hospital Aarhus, Denmark
- Rigshospitalet Copenhagen, Denmark
- Odense University Hospital Odense, Denmark
NCT03980002
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin, Tianjin Municipality, China
NCT02869529
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Institut Paoli-Calmettes Marseille, Bouches-du Rhône, France
Enrolling by Invitation
Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia
NCT06773936
- Conditions
- CD19+ Acute Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- UC Irvine Medical Center Orange, California, United States
- Northwell Health/Center for Advanced Medicine Lake Success, New York, United States
- University of Rochester Medical Center Rochester, New York, United States
- Duke University Medical Center Durham, North Carolina, United States
Enrolling by Invitation
Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies
NCT02473757
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +21 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Enrolling by Invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
NCT06788509
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +30 more
- Locations
-
- Linear Clinical Research Ltd Nedlands, Australia
- Scientia Clinical Research Randwick, Australia
- Ghent University Hospital Ghent, Belgium
- Hopital Claude Huriez Lille, France
Enrolling by Invitation
VR-PAT During Home Burn Dressings - Multisite
NCT05673551
- Conditions
- Acute Pain, Burns, Hematologic Diseases, +19 more
- Locations
-
- Nationwide Children's Hospital Columbus, Ohio, United States
- Parkland Health & Hospital System Dallas, Texas, United States
Enrolling by Invitation
RVU120 Rollover Study
NCT06987058
- Conditions
- Acute Myeloid Leukaemia (AML), Advanced Solid Tumors, Bone Marrow Diseases, +15 more
- Locations
-
- Uniwersyteckie Centrum Kliniczne Gdansk, Poland
- Clinica Universidad de Navarra Pamplona, Spain
Enrolling by Invitation
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
NCT04093570
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
- Locations
-
- Compassionate Care Research Group Fountain Valley, California, United States
- Boca Raton Clinical Research Plantation, Florida, United States
- The University of Chicago Medical Center Chicago, Illinois, United States
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins Baltimore, Maryland, United States